ZeClinics Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
38
- Latest Deal Type
-
Angel
- (Cancelled)
- Latest Deal Amount
-
$5.67M
- Investors
-
1
ZeClinics General Information
Description
Developer of a biotechnology platform designed to develop drugs and pharmaceuticals using zebrafish. The company's platform tracks toxicity data, preserves embryos of marine species, tests and utilizes zebrafish larvae in toxicology screening of drugs and related protein molecules, enabling biotechnologists to test the toxicity of drugs and recommend dosage with the help of zebrafish screening and nullification.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
- C/Marina 25-27
- 08005 Barcelona
- Spain
+34 930 00 00 00
ZeClinics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Angel (individual) | 19-Jan-2022 | $5.67M | Cancelled | Generating Revenue | ||
| 2. Grant | 01-Dec-2016 | 00.000 | 00000 | Completed | Generating Revenue | |
| 1. Equity Crowdfunding | 31-May-2015 | $112K | $112K | 00.000 | Completed | Generating Revenue |
ZeClinics Executive Team (4)
ZeClinics Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Davide D'Amico Ph.D | ZeClinics | Co-Founder & Chairman | 000 0000 |
| Ignasi Sahún Abizanda Ph.D | ZeClinics | Co-Founder, Chief Operating Officer & Board Member | 000 0000 |
| Javier Terriente Ph.D | ZeClinics | Co-Founder, Chief of Drug Development & Board Member | 000 0000 |
| Simone Calzolari Ph.D | ZeClinics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
ZeClinics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
ZeClinics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Horizon 2020 SME Instrument | Government | 000 0000 | 000000 0 |